News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Drug Development
Roche Seeks To Broaden Arthritis Drug Roactemra Use In EU, US
October 18, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
ZURICH, Oct 18 (Reuters) - Roche Holding AG (ROG.VX) is seeking approval to broaden the use of its arthritis drug Roactemra in Europe and the United States to treat a type of childhood arthritis, giving the group a lift after a series of setbacks.
Twitter
LinkedIn
Facebook
Email
Print
Clinical research
Postmarket research
Europe
Roche
MORE ON THIS TOPIC
Earnings
Sanofi’s Legacy Vaccine Sales Decline As Americans Skip Flu Shots
October 24, 2025
·
2 min read
·
Annalee Armstrong
Cystic fibrosis
Arcturus Plunges on ‘Mixed’ Cystic Fibrosis Data for Inhaled mRNA Drug
October 23, 2025
·
2 min read
·
Tristan Manalac
Vaccines
Moderna Scraps CMV Vaccine After Phase III Fail
October 23, 2025
·
3 min read
·
Tristan Manalac
Cancer
ADC, Bispecifics and Kinase Blockers Steal the Spotlight at ESMO 2025 in Berlin
October 22, 2025
·
4 min read
·
Tristan Manalac
